Print Page  |  Close Window

SEC Filings

10-Q
TERRAFORM GLOBAL, INC. filed this Form 10-Q on 08/09/2017
Entire Document
 

TERRAFORM GLOBAL, INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)


Six Months Ended June 30,
 
2017
 
2016
Cash flows from operating activities:
 
 
 
Net loss
$
(19,698
)
 
$
(567
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
Amortization of deferred financing costs
1,284

 
1,768

Depreciation, amortization and accretion
36,310

 
27,597

Stock-based compensation expense
1,818

 
1,972

Change in fair value of interest rate swaps
1,814

 
4,638

Loss on disposal of property
885

 

Loss (gain) on extinguishment of debt
6,767

 
(5,735
)
Unrealized gains on foreign currency, net
(29,823
)
 
(21,239
)
Deferred tax benefit
(557
)
 
(511
)
Other non-cash items
(2,348
)
 

Changes in assets and liabilities:
 
 
 
Accounts receivable
1,324

 
3,366

Prepaid expenses and other current assets
(15,094
)
 
7,037

Accounts payable, accrued expenses, and other current liabilities
10,224

 
(11,544
)
Due to/from affiliates, net
(6,338
)
 
(3,192
)
Net cash (used in) provided by operating activities
(13,432
)
 
3,590

Cash flows from investing activities:
 
 
 
Capital expenditures
(3,486
)
 
(47,105
)
Change in restricted cash
2,778

 
57,103

Cash paid for acquisitions, net of cash acquired

 
(32,128
)
Cash acquired upon FERSA consolidation

 
8,022

Returns from BioTherm escrow and deposits
2,430

 
3,775

Net cash provided by (used in) investing activities
1,722

 
(10,333
)
Cash flows from financing activities:


 
 
Repayments of the Senior Notes

 
(35,441
)
Repayments of system debt financing
(7,906
)
 
(29,477
)
Net SunEdison investment

 
48,983

Dividends paid

 
(30,674
)
Net cash used in financing activities
(7,906
)
 
(46,609
)
Net decrease in cash and cash equivalents
(19,616
)
 
(53,352
)
Effect of exchange rate changes on cash and cash equivalents
(11,036
)
 
1,528

Cash and cash equivalents at beginning of period
680,893

 
922,318

Cash and cash equivalents at end of period
$
650,241

 
$
870,494

See accompanying notes to unaudited condensed consolidated financial statements.

8